{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T13:27:11Z","timestamp":1761744431086},"reference-count":51,"publisher":"Public Library of Science (PLoS)","issue":"11","license":[{"start":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T00:00:00Z","timestamp":1478736000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/publicdomain\/zero\/1.0\/"}],"funder":[{"name":"Intramural Research Program of the National Institutes of Health"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0166036","type":"journal-article","created":{"date-parts":[[2016,11,10]],"date-time":"2016-11-10T18:55:43Z","timestamp":1478804143000},"page":"e0166036","update-policy":"http:\/\/dx.doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":10,"title":["Vitamin D Status and Virologic Response to HCV Therapy in the HALT-C and VIRAHEP-C Trials"],"prefix":"10.1371","volume":"11","author":[{"given":"Erikka","family":"Loftfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas R.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth M.","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charles D.","family":"Howell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludmila","family":"Prokunina-Olsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie J.","family":"Weinstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Demetrius","family":"Albanes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Timothy R.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neal D.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2016,11,10]]},"reference":[{"issue":"2","key":"ref1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1469-0691.2010.03432.x","article-title":"Evolving epidemiology of hepatitis C virus","volume":"17","author":"D Lavanchy","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"ref2","unstructured":"WHO. Hepatitis C 2002 [October 7, 2015]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo2003\/en\/index4.html\" xlink:type=\"simple\">http:\/\/www.who.int\/csr\/disease\/hepatitis\/whocdscsrlyo2003\/en\/index4.html<\/ext-link>."},{"issue":"11","key":"ref3","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.3748\/wjg.14.1652","article-title":"Natural history of hepatitis-related hepatocellular carcinoma","volume":"14","author":"DY But","year":"2008","journal-title":"World J Gastroenterol"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1478-3231.2007.01652.x","article-title":"Viral hepatocarcinogenesis: from infection to cancer","volume":"28","author":"A Tan","year":"2008","journal-title":"Liver Int"},{"issue":"9859","key":"ref5","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"R Lozano","year":"2012","journal-title":"Lancet"},{"issue":"13","key":"ref6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMoa020047","article-title":"Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection","volume":"347","author":"MW Fried","year":"2002","journal-title":"N Engl J Med"},{"issue":"9286","key":"ref7","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S0140-6736(01)06102-5","article-title":"Peginterferon alfa-2b plus ribavirin compared with interferon alfa-2b plus ribavirin for initial treatment of chronic hepatitis C: a randomised trial","volume":"358","author":"MP Manns","year":"2001","journal-title":"Lancet"},{"issue":"8","key":"ref8","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1056\/NEJM199908193410802","article-title":"The prevalence of hepatitis C virus infection in the United States, 1988 through 1994","volume":"341","author":"MJ Alter","year":"1999","journal-title":"N Engl J Med"},{"issue":"6","key":"ref9","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/hep.20212","article-title":"Peginterferon alfa-2a (40 kd) and ribavirin for black American patients with chronic HCV genotype 1","volume":"39","author":"LJ Jeffers","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/cid\/cir774","article-title":"Boceprevir and telaprevir in the management of hepatitis C virus-infected patients","volume":"54","author":"AA Butt","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"16","key":"ref11","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMe1401508","article-title":"Therapy for hepatitis C\u2014the costs of success","volume":"370","author":"JH Hoofnagle","year":"2014","journal-title":"N Engl J Med"},{"issue":"11","key":"ref12","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/j.cgh.2013.05.014","article-title":"Cost effectiveness of direct-acting antiviral therapy for treatment-naive patients with chronic HCV genotype 1 infection in the veterans health administration","volume":"11","author":"K Chan","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"4","key":"ref13","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1002\/hep.26246","article-title":"A global view of hepatitis C: physician knowledge, opinions, and perceived barriers to care","volume":"57","author":"CE McGowan","year":"2013","journal-title":"Hepatology"},{"issue":"7","key":"ref14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S1473-3099(15)00006-7","article-title":"Hepatitis C seroprevalence and HIV co-infection in sub-Saharan Africa: a systematic review and meta-analysis","volume":"15","author":"VB Rao","year":"2015","journal-title":"Lancet Infect Dis"},{"issue":"4","key":"ref15","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence","volume":"57","author":"K Mohd Hanafiah","year":"2013","journal-title":"Hepatology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1136\/gutjnl-2015-310421","article-title":"Hepatitis C virus treatment in the real world: optimising treatment and access to therapies","volume":"64","author":"F Zoulim","year":"2015","journal-title":"Gut"},{"issue":"2","key":"ref17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1053\/j.gastro.2006.06.008","article-title":"Peginterferon and ribavirin treatment in African American and Caucasian American patients with hepatitis C genotype 1","volume":"131","author":"HS Conjeevaram","year":"2006","journal-title":"Gastroenterology"},{"key":"ref18","article-title":"Comparison of Functional Variants in IFNL4 and IFNL3 for Association with Hepatitis C Virus Clearance","author":"TR O'Brien","year":"2015","journal-title":"J Hepatol"},{"issue":"2","key":"ref19","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng.2521","article-title":"A variant upstream of IFNL3 (IL28B) creating a new interferon gene IFNL4 is associated with impaired clearance of hepatitis C virus","volume":"45","author":"L Prokunina-Olsson","year":"2013","journal-title":"Nat Genet"},{"issue":"3","key":"ref20","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1093\/infdis\/jit433","article-title":"Association of the IFNL4-DeltaG Allele With Impaired Spontaneous Clearance of Hepatitis C Virus","volume":"209","author":"PV Aka","year":"2014","journal-title":"J Infect Dis"},{"issue":"8","key":"ref21","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1056\/NEJMoa1501315","article-title":"Ledipasvir and Sofosbuvir for HCV in Patients Coinfected with HIV-1","volume":"373","author":"S Naggie","year":"2015","journal-title":"N Engl J Med"},{"issue":"47","key":"ref22","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.3748\/wjg.v17.i47.5184","article-title":"Vitamin D supplementation improves sustained virologic response in chronic hepatitis C (genotype 1)-naive patients","volume":"17","author":"S Abu-Mouch","year":"2011","journal-title":"World J Gastroenterol"},{"issue":"1","key":"ref23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1432-2277.2010.01141.x","article-title":"Vitamin D supplementation improves response to antiviral treatment for recurrent hepatitis C","volume":"24","author":"D Bitetto","year":"2011","journal-title":"Transpl Int"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/j.jhep.2010.08.036","article-title":"Vitamin D deficiency and a CYP27B1-1260 promoter polymorphism are associated with chronic hepatitis C and poor response to interferon-alfa based therapy","volume":"54","author":"CM Lange","year":"2011","journal-title":"J Hepatol"},{"issue":"9","key":"ref25","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nri2378","article-title":"Vitamin effects on the immune system: vitamins A and D take centre stage","volume":"8","author":"JR Mora","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1196\/annals.1402.070","article-title":"Vitamin D: molecular mechanism of action","volume":"1116","author":"S Christakos","year":"2007","journal-title":"Ann N Y Acad Sci"},{"issue":"4","key":"ref27","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1002\/hep.25763","article-title":"25-Hydroxyvitamin D3 suppresses hepatitis C virus production","volume":"56","author":"T Matsumura","year":"2012","journal-title":"Hepatology"},{"issue":"5","key":"ref28","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1002\/hep.24575","article-title":"Vitamin D: an innate antiviral agent suppressing hepatitis C virus in human hepatocytes","volume":"54","author":"M Gal-Tanamy","year":"2011","journal-title":"Hepatology"},{"issue":"6","key":"ref29","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1128\/AAC.01426-06","article-title":"Comprehensive analysis of the effects of ordinary nutrients on hepatitis C virus RNA replication in cell culture","volume":"51","author":"M Yano","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"ref30","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.jhep.2014.08.004","article-title":"Vitamin D level and sustained virologic response to interferon-based antiviral therapy in chronic hepatitis C: a systematic review and meta-analysis","volume":"61","author":"MT Kitson","year":"2014","journal-title":"J Hepatol"},{"issue":"5","key":"ref31","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/hep.27281","article-title":"Relationship of vitamin D status with advanced liver fibrosis and response to hepatitis C virus therapy: a meta-analysis","volume":"60","author":"M Garcia-Alvarez","year":"2014","journal-title":"Hepatology"},{"key":"ref32","unstructured":"Ross AC, Taylor CL, Yaktine AL, DelValle HB. Dietary Reference Intakes for Calcium and Vitamin D. Institute of Medicine, 2011."},{"issue":"5","key":"ref33","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.cct.2004.08.003","article-title":"Evolution of the HALT-C Trial: pegylated interferon as maintenance therapy for chronic hepatitis C in previous interferon nonresponders","volume":"25","author":"WM Lee","year":"2004","journal-title":"Control Clin Trials"},{"issue":"23","key":"ref34","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1056\/NEJMoa0707615","article-title":"Prolonged therapy of advanced chronic hepatitis C with low-dose peginterferon","volume":"359","author":"AM Di Bisceglie","year":"2008","journal-title":"N Engl J Med"},{"issue":"4","key":"ref35","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1053\/j.gastro.2004.01.014","article-title":"Peginterferon alfa-2a and ribavirin in patients with chronic hepatitis C who have failed prior treatment","volume":"126","author":"ML Shiffman","year":"2004","journal-title":"Gastroenterology"},{"issue":"1","key":"ref36","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1128\/JCM.42.1.421-425.2004","article-title":"Strengths and limitations of commercial tests for hepatitis C virus RNA quantification","volume":"42","author":"C Morishima","year":"2004","journal-title":"J Clin Microbiol"},{"issue":"7","key":"ref37","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2011.02.061","article-title":"Coffee Consumption Is Associated With Response to Peginterferon and Ribavirin Therapy in Patients With Chronic Hepatitis C","volume":"140","author":"ND Freedman","year":"2011","journal-title":"Gastroenterology"},{"issue":"4","key":"ref38","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/hep.20119","article-title":"Diagnosis, management, and treatment of hepatitis C","volume":"39","author":"DB Strader","year":"2004","journal-title":"Hepatology"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1093\/aje\/kwq116","article-title":"Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers","volume":"172","author":"L Gallicchio","year":"2010","journal-title":"Am J Epidemiol"},{"issue":"15","key":"ref40","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.clinbiochem.2009.07.013","article-title":"An evaluation of automated methods for measurement of serum 25-hydroxyvitamin D","volume":"42","author":"D Wagner","year":"2009","journal-title":"Clin Biochem"},{"key":"ref41","article-title":"Encyclopedia of Statistical Sciences","author":"JD Gibbons","year":"2004"},{"issue":"1","key":"ref42","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"AC Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"issue":"1","key":"ref43","first-page":"85","article-title":"A multivariate technique for multiply imputing missing values using a sequence of regression models","volume":"27","author":"TE Raghunathan","year":"2001","journal-title":"Survey Methodology"},{"issue":"11","key":"ref44","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"JP Higgins","year":"2002","journal-title":"Statistics in medicine"},{"key":"ref45","article-title":"Relationship between vitamin D status and response to hepatitis C virus therapy","author":"MT Kitson","year":"2015","journal-title":"Hepatology"},{"issue":"3","key":"ref46","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/hep.26186","article-title":"Vitamin A deficiency is associated with hepatitis C virus chronic infection and with unresponsiveness to interferon-based antiviral therapy","volume":"57","author":"D Bitetto","year":"2013","journal-title":"Hepatology"},{"issue":"5","key":"ref47","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1002\/hep.25848","article-title":"Vitamin D binding protein gene polymorphisms and baseline vitamin D levels as predictors of antiviral response in chronic hepatitis C","volume":"56","author":"E Falleti","year":"2012","journal-title":"Hepatology"},{"issue":"4","key":"ref48","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1002\/hep.24201","article-title":"Complementary role of vitamin D deficiency and the interleukin-28B rs12979860 C\/T polymorphism in predicting antiviral response in chronic hepatitis C","volume":"53","author":"D Bitetto","year":"2011","journal-title":"Hepatology"},{"issue":"5","key":"ref49","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1002\/hep.27796","article-title":"Reply: To PMID 24975775","volume":"62","author":"D Pineda-Tenor","year":"2015","journal-title":"Hepatology"},{"issue":"5","key":"ref50","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.3945\/ajcn.112.039974","article-title":"Vitamin D and the racial difference in the genotype 1 chronic hepatitis C treatment response","volume":"96","author":"SJ Weintraub","year":"2012","journal-title":"Am J Clin Nutr"},{"issue":"3","key":"ref51","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jhep.2012.11.017","article-title":"Vitamin D status does not predict sustained virologic response or fibrosis stage in chronic hepatitis C genotype 1 infection","volume":"58","author":"MT Kitson","year":"2013","journal-title":"J Hepatol"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0166036","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,20]],"date-time":"2023-08-20T21:33:59Z","timestamp":1692567239000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0166036"}},"subtitle":[],"editor":[{"given":"Chien-Wei","family":"Su","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2016,11,10]]},"references-count":51,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2016,11,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0166036","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,11,10]]}}}